Presa Diretta, the broadcast reporting on the Italian hottest news, interviews Exiris CSO on pharmaceutical research and drugs costs, and on the potential spreading benefits that can raise from the collaboration between private and public research, with Exiris presenting itself as a model of this private/public synergy aimed at increasing the probability of success and decreasing the costs of drug research.
Broadcast on March 13th 2016.
Comments are closed.